Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden · Delayed Price · Currency is SEK 17.24
+0.86 (5.25%)
At close: Feb 9, 2026
Diamyd Medical AB Market Cap
Diamyd Medical AB has a market cap or net worth of 2.37 billion as of February 10, 2026. Its market cap has increased by 30.88% in one year.
Market Cap
2.37B
Enterprise Value
2.14B
Revenue
349.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
17.24
Market Cap Chart
Since May 20, 2013, Diamyd Medical AB's market cap has increased from 132.51M to 2.37B, an increase of 1,688.86%. That is a compound annual growth rate of 25.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 2.37B | 53.11% |
| Dec 30, 2025 | 1.55B | -9.52% |
| Dec 30, 2024 | 1.71B | 182.47% |
| Dec 29, 2023 | 605.80M | -41.10% |
| Dec 30, 2022 | 1.03B | -9.66% |
| Dec 30, 2021 | 1.14B | -46.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.69B |
| Saniona AB | 3.35B |
| Vicore Pharma Holding AB | 2.91B |
| Flerie AB | 2.77B |
| Egetis Therapeutics AB | 1.97B |
| BioInvent International AB | 1.71B |
| Genovis AB (publ.) | 1.35B |
| Cantargia AB | 1.32B |